ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,000 | +50.0% | 12,714 | +8.5% | 0.00% | +33.3% |
| Q3 2020 | $6,000 | -33.3% | 11,714 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $9,000 | -18.2% | 11,714 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $11,000 | -54.2% | 11,714 | 0.0% | 0.01% | -40.0% |
| Q4 2019 | $24,000 | -29.4% | 11,714 | 0.0% | 0.01% | -28.6% |
| Q3 2019 | $34,000 | -62.2% | 11,714 | 0.0% | 0.01% | -64.1% |
| Q2 2019 | $90,000 | -42.3% | 11,714 | 0.0% | 0.04% | -41.8% |
| Q1 2019 | $156,000 | -14.8% | 11,714 | 0.0% | 0.07% | -26.4% |
| Q4 2018 | $183,000 | -20.4% | 11,714 | 0.0% | 0.09% | -1.1% |
| Q3 2018 | $230,000 | -31.5% | 11,714 | 0.0% | 0.09% | -39.1% |
| Q2 2018 | $336,000 | +21.3% | 11,714 | 0.0% | 0.15% | +20.8% |
| Q1 2018 | $277,000 | – | 11,714 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |